We have updated our privacy policy. If you have any question, contact us at privacy@scicrunch.org. Dismiss and don't show again

Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Tumour predisposition in mice heterozygous for a targeted mutation in Nf1.

Nature genetics | Jul 17, 1994

Human neurofibromatosis type 1 is a dominant disease caused by the inheritance of a mutant allele of the NF1 gene. In order to study NF1 function, we have constructed a mouse strain carrying a germline mutation in the murine homologue. Heterozygous animals do not exhibit the classical symptoms of the human disease, but are highly predisposed to the formation of various tumour types, notably phaeochomocytoma, a tumour of the neural crest-derived adrenal medulla, and myeloid leukaemia, both of which occur with increased frequency in human NF1 patients. The wild-type Nf1 allele is lost in approximately half of the tumours from heterozygous animals. In addition, homozygosity for the Nf1 mutation leads to abnormal cardiac development and mid-gestational embryonic lethality.

Pubmed ID: 7920653 RIS Download

Mesh terms: Adrenal Gland Neoplasms | Alleles | Animals | Base Sequence | Disease Models, Animal | Fetal Death | Genes, Lethal | Genes, Neurofibromatosis 1 | Genes, Synthetic | Genetic Predisposition to Disease | Heart Defects, Congenital | Heterozygote | Humans | Leukemia, Myeloid | Mice | Mice, Knockout | Mice, Mutant Strains | Molecular Sequence Data | Neoplastic Syndromes, Hereditary | Neurofibromatosis 1 | Neurofibromin 1 | Phenotype | Pheochromocytoma | Proteins | Species Specificity

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants


Mouse Genome Informatics (Data, Gene Annotation)

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.